The existence of glycine residues in long-chain scorpion toxins has been well documented. However, their role as analgesics has not been evaluated. To address this issue, we investigated the functional role of glycines in the C-terminal end of Chinese-scorpion toxin from Buthus martensii Karsch (BmK AGP-SYPU2) using site-directed mutagenesis and analgesic activity assays. Recombinant BmK AGP-SYPU2 and its mutants were efficiently expressed in E. coli and purified to homogeneity using immobilized metal ion affinity chromatography (IMAC) and cation exchange chromatography. The mouse-twisting test was used to detect the analgesic activity of BmK AGP-SYPU2 and its mutants. As a result, we identified glycines at the C-terminal end that, when altered, significantly affected analgesic activity. Also, Mut6566 was significantly decreased compared to BmK AGP-SYPU2. These data indicate that the glycines at the C-terminal end are important for the analgesic activity of BmK AGP-SYPU2. [BMB reports 2010; 43(12): 801-806]
INTRODUCTION
Scorpion venoms are a rich source of neurotoxic proteins that modulate various ion channels, including Na + , K + , Ca 2+ and Cl -, in excitable membranes (1). Scorpion long-chain neurotoxins (LCNs) are composed of 61-76 amino acid residues. Based on their mode of action and binding properties, LCNs affecting voltage-gated Na + channels (VGSCs) are divided into two classes: α-and β-toxins. Scorpion α-toxins are further divided into three different pharmacological subfamilies according to their preferential activities against mammals and insects. These subfamilies include classical α-mammal toxins, insect α-toxins, and α-like toxins (2). A better understanding of these toxins' structure-function relationships can be obtained by using site-directed mutagenesis.
This method generates different mutants to study their interaction with the target channels (3, 4). It has been predicted that the N-and C-termini are important for the interaction of these toxins with their target channels (5). Most LCNs share a common structural framework consisting of three double-stranded anti-parallel β-sheets linked to a short α-helix. The reverse turn in residues 8-12 and the C-terminal segment in residues 58-64 are closely connected by a fourth disulfide bond (Cys12-Cys63) to form a unique tertiary entity (reverse turn and C-terminal, Site RC) (6). This entity is believed to mediate a high-affinity interaction with the receptor (7). Extensive mutagenesis studies on this functional domain have successfully been carried out on scorpion α-toxins, such as Lqh αIT from Leiurus quinquestriatus hebraeus (8-10) and BmK M1 from Buthus martensii . These studies shed some light on the structural and functional anatomy of scorpion α-toxins, which consist of three major functional domains. These studies also showed that some residues, particularly those found in the C-terminal region, are important for the formation of an electrostatic potential involved in receptor recognition and toxic activity. However, there has been no research on the contribution of C-terminal glycine residues on analgesic activity. A number of analgesic scorpion toxins have been identified and characterized from scorpion venom, but the structure-function relationship and the location of the functional site of these toxins still remain to be determined. In our previous studies, site-directed mutagenesis was applied to the conserved hydrophobic surface and disulfide bridges in an antitumor-analgesic peptide to determine the analgesic domain (14, 15). Our lab is interested in BmK AGP-SYPU2, which has been isolated and purified by ion exchange chromatography, hydrophobic interaction chromatography and gel filtration chromatography from the Buthus martensii Karsch (BmK) and was shown to have an analgesic effect at the animal level (data not shown). The sequence determination showed that the mature peptide of BmK AGP-SYPU2 is composed of 66 amino acid residues and is identical to BmK alpha2 (GenBank Accession No. AF288608) and BmK alphaTX11 (GenBank Accession No. AF155364). Double glycines are located at the C-terminal end of BmK AGP-SYPU2, which are hypothesized to be essential for its bioactivity.
However, limited availability of toxins from natural sources makes it difficult to characterize their structure-function rela-http://bmbreports.org The inhibition efficiency is the ratio (T0-T)/T0, where T0 is the mean twisting time of the negative control group and T is the mean twisting time of the experiment groups with rBmK AGP-SYPU2, mutants and morphine. (n=10). tionships and interaction with sodium channels. In this study, we cloned the gene encoding BmK AGP-SYPU2 and successfully expressed a biologically active recombinant toxin and two mutants in E. coli in sufficient amounts, obtained by site-directed mutagenesis PCR. We focused on the C-terminal contribution to BmK AGP-SYPU2's biological properties. Glycines at the C-terminal end (65-66) of BmK AGP-SYPU2 were deleted one by one. The first mutant was obtained by deleting one glycine at the C-terminal (Mut66) and the second mutant by deleting two glycines at the C-terminal end (Mut6566). The results of the mutagenesis, expression, purification, and analgesic activity assays of these mutants are reported here. From this study, we propose that the glycine residues are important for the analgesic activity of these mutants. Remarkably, deleting two glycine residues can alter the analgesic activity significantly.
RESULTS

Expression, purification, and characterization of BmK AGP-SYPU2 and its mutants
To evaluate the impact of the Chinese-scorpion toxin BmK AGP-SYPU2's C-terminal end on analgesic activity, we constructed and expressed recombinant BmK AGP-SYPU2 (rBmK AGP-SYPU2), Mut66 and Mut6566 toxins using the E. coli BL21 (λDE3) system. We used this system to obtain significant amounts of rBmK AGP-SYPU2 toxin and its mutated forms. The recombinant proteins were mostly expressed in soluble form, and then they were isolated from soluble fractions in the E. coli cell lysate and purified to homogeneity using IMAC (Fig. 1a, b) and cation exchange chromatography (Fig. 1c, d) . The apparent molecular weight of 9 kDa was consistent with the theoretical calculated values deduced from the toxin sequence. The rBmK AGP-SYPU2 and mutants were assessed by 15% SDS-PAGE (Fig. 2a) and high performance capillary electrophoresis (HPCE) (Fig. 2b) . Purity was greater than 90% as judged by Coomassie staining of the SDS-PAGE gel.
Analgesic activity assays of BmK AGP-SYPU2 and its mutants
The mouse-twisting reaction test was carried out at a dose of 2.72 × 10 -2 μmol/kg (Table 1) . We studied the analgesic activity of the recombinant toxins by injecting 200 μl of a solution containing purified rBmK AGP-SYPU2 or its mutants intraperitoneally into mice. The analgesic activities of these sam-
